SHAHLA ALI: Open Payments
NPI 1740505957 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,683 in 94 payments from 16 companies in 2025. Trend: 2023 $15,241 · 2024 $1,572 · 2025 $1,683
Food & beverage: $1,573Education: $109
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $462 |
| Janssen Pharmaceuticals, Inc | 10 | $291 |
| Corium, LLC | 8 | $190 |
| Vanda Pharmaceuticals Inc. | 9 | $164 |
| Teva Pharmaceuticals USA, Inc. | 3 | $157 |
| Supernus Pharmaceuticals, Inc. | 4 | $83 |
| Neurocrine BioSciences, Inc. | 2 | $77 |
| Alkermes, Inc. | 3 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
Products named: VRAYLAR, SPRAVATO, Azstarys, FANAPT, INVEGA SUSTENNA, Qelbree, INGREZZA, HETLIOZ.
Industry payments across TX — which companies pay providers there.
